Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol

관리자
조회수 283

Medicine®  /  September 18, 2020


Phase I study to evaluate the maximum tolerated 
dose of the combination of SH003 and 
docetaxel in patients with solid cancer: A study protocol


Link;

https://journals.lww.com/md-journal/Fulltext/2020/09180/Phase_I_study_to_evaluate_the_maximum_tolerated.60.aspx

 


(주)재인알앤피

서울특별시 동대문구 경희대로23 

경희대학교 서울바이오 산학협력센터 604호

  대표전화  02-961-0329

대표메일  info@jaeinrnp.com

Copyright 2021.Jaein R&P Corp, all right reserved


서울특별시 동대문구 경희대로23 경희대학교 서울바이오 산학협력센터 604호

 대표전화  02-961-0329 대표메일  info@jaeinrnp.com

Copyright 2021. Jaein R&P Corp all right reserved